First Time Loading...

ReShape Lifesciences Inc
NASDAQ:RSLS

Watchlist Manager
ReShape Lifesciences Inc Logo
ReShape Lifesciences Inc
NASDAQ:RSLS
Watchlist
Price: 0.168 USD 0.18% Market Closed
Updated: May 12, 2024

ReShape Lifesciences Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ReShape Lifesciences Inc
Income from Continuing Operations Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
ReShape Lifesciences Inc
NASDAQ:RSLS
Income from Continuing Operations
-$11.4m
CAGR 3-Years
3%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Income from Continuing Operations
$1.3B
CAGR 3-Years
7%
CAGR 5-Years
-2%
CAGR 10-Years
3%
Boston Scientific Corp
NYSE:BSX
Income from Continuing Operations
$1.8B
CAGR 3-Years
92%
CAGR 5-Years
0%
CAGR 10-Years
17%
Stryker Corp
NYSE:SYK
Income from Continuing Operations
$3.4B
CAGR 3-Years
34%
CAGR 5-Years
11%
CAGR 10-Years
16%
Abbott Laboratories
NYSE:ABT
Income from Continuing Operations
$5.6B
CAGR 3-Years
-1%
CAGR 5-Years
16%
CAGR 10-Years
13%
Intuitive Surgical Inc
NASDAQ:ISRG
Income from Continuing Operations
$2B
CAGR 3-Years
19%
CAGR 5-Years
12%
CAGR 10-Years
14%

See Also

What is ReShape Lifesciences Inc's Income from Continuing Operations?
Income from Continuing Operations
-11.4m USD

Based on the financial report for Dec 31, 2023, ReShape Lifesciences Inc's Income from Continuing Operations amounts to -11.4m USD.

What is ReShape Lifesciences Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
21%

Over the last year, the Income from Continuing Operations growth was 75%. The average annual Income from Continuing Operations growth rates for ReShape Lifesciences Inc have been 3% over the past three years , 21% over the past five years .